1. Home /
  2. Oral Anti-Cancer Drug (OACD) Fees

Oral Anti-Cancer Drug (OACD) Fees

OACDs are billed using the National Drug Code (NDC). Such drug fees are subject to change on a quarterly basis. Currently, these drugs meet the requirements for coverage under the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). They are not assigned HCPCS codes.

Lists contain Drug Manufacturers, Strength of Drug, NDC, and Allowable based on Average Sales Price (ASP)

Year Quarter
2018 Quarter 4 - Updated 09/18/2018
Quarter 3 - Updated 06/20/2018
Quarter 2 - Updated 03/23/2018
Quarter 1 - Updated 12/20/2017
2017 Quarter 4 - Updated 10/03/2017
Quarter 3 - Updated 10/03/2017
Quarter 2 - Updated 03/22/2017
Quarter 1 - Updated 12/27/2016
2016 Quarter 4 - Updated 09/23/2016
Quarter 3 - Updated 06/27/2016
Quarter 2 - Updated 03/29/2016
Quarter 1 - Updated 03/29/2016
2015 Quarter 4 - Updated 09/23/2015
Quarter 3 - Updated 06/23/2015
Quarter 2 - Updated 03/25/2015
Quarter 1 - Updated 01/27/2015
2014 Quarter 4 - Updated 09/29/2014
Quarter 3 - Updated 06/24/2014
Quarter 2 - Updated 03/25/2014
Quarter 1 - Updated 01/27/2014

Note: This information is provided as a service to our customers. While every effort is made to ensure the accuracy of this information up to our publication deadline, we are not responsible for any errors or subsequent changes. There is no eligibility guarantee for reimbursement based on using this information. Reimbursement is based on factors including, but not limited to: disease diagnosis, medical necessity for the DMEPOS item and the Medicare program coverage guidelines.

Inclusion or exclusion of a fee schedule amount for an item or service does not imply any health insurance coverage.

Quarter 1 = January 1 - March 31
Quarter 2 = April 1 - June 30
Quarter 3 = July 1 - September 30
Quarter 4 = October 1 - December 31

If older files are needed, contact the PDAC Contact Center.